FineMark National Bank & Trust reduced its holdings in shares of CVS Health Corp (NYSE:CVS) by 47.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 9,659 shares of the pharmacy operator’s stock after selling 8,836 shares during the period. FineMark National Bank & Trust’s holdings in CVS Health were worth $760,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Kiley Juergens Wealth Management LLC lifted its position in CVS Health by 41.5% in the 3rd quarter. Kiley Juergens Wealth Management LLC now owns 2,270 shares of the pharmacy operator’s stock valued at $178,000 after acquiring an additional 666 shares in the last quarter. Northwest Investment Counselors LLC lifted its position in CVS Health by 2.5% in the 3rd quarter. Northwest Investment Counselors LLC now owns 29,103 shares of the pharmacy operator’s stock valued at $2,291,000 after acquiring an additional 704 shares in the last quarter. Security National Bank of Sioux City Iowa IA lifted its position in CVS Health by 3.3% in the 2nd quarter. Security National Bank of Sioux City Iowa IA now owns 22,523 shares of the pharmacy operator’s stock valued at $1,449,000 after acquiring an additional 720 shares in the last quarter. Pitcairn Co. lifted its position in CVS Health by 8.2% in the 3rd quarter. Pitcairn Co. now owns 9,645 shares of the pharmacy operator’s stock valued at $760,000 after acquiring an additional 728 shares in the last quarter. Finally, Twin Capital Management Inc. lifted its position in CVS Health by 0.7% in the 2nd quarter. Twin Capital Management Inc. now owns 108,530 shares of the pharmacy operator’s stock valued at $6,984,000 after acquiring an additional 730 shares in the last quarter. Hedge funds and other institutional investors own 82.55% of the company’s stock.

CVS Health stock opened at $80.80 on Wednesday. CVS Health Corp has a 52 week low of $60.14 and a 52 week high of $83.88. The company has a current ratio of 2.44, a quick ratio of 1.94 and a debt-to-equity ratio of 1.66. The company has a market cap of $81.85 billion, a price-to-earnings ratio of 11.78, a PEG ratio of 1.07 and a beta of 0.98.

CVS Health (NYSE:CVS) last posted its earnings results on Tuesday, November 6th. The pharmacy operator reported $1.73 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.71 by $0.02. CVS Health had a net margin of 1.65% and a return on equity of 18.69%. The firm had revenue of $47.27 billion for the quarter, compared to analysts’ expectations of $47.22 billion. During the same quarter last year, the firm earned $1.50 EPS. The company’s quarterly revenue was up 2.4% compared to the same quarter last year. As a group, sell-side analysts expect that CVS Health Corp will post 7.04 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Thursday, November 1st. Shareholders of record on Wednesday, October 24th were given a dividend of $0.50 per share. The ex-dividend date was Tuesday, October 23rd. This represents a $2.00 annualized dividend and a dividend yield of 2.48%. CVS Health’s dividend payout ratio is currently 33.90%.

In other news, EVP Kevin Hourican sold 8,564 shares of the firm’s stock in a transaction that occurred on Monday, August 27th. The shares were sold at an average price of $75.00, for a total transaction of $642,300.00. Following the completion of the sale, the executive vice president now owns 12,135 shares in the company, valued at approximately $910,125. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Lisa Bisaccia sold 21,534 shares of the firm’s stock in a transaction that occurred on Monday, October 1st. The stock was sold at an average price of $80.00, for a total transaction of $1,722,720.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 43,409 shares of company stock worth $3,392,097. Insiders own 0.53% of the company’s stock.

Several equities analysts recently weighed in on CVS shares. Bank of America raised their price target on shares of CVS Health from $86.00 to $90.00 and gave the company a “buy” rating in a research report on Monday, September 17th. ValuEngine cut shares of CVS Health from a “sell” rating to a “strong sell” rating in a research report on Tuesday, September 4th. Royal Bank of Canada raised their price target on shares of CVS Health to $101.00 and gave the company an “outperform” rating in a research report on Tuesday, September 18th. Tigress Financial reaffirmed a “buy” rating on shares of CVS Health in a research report on Friday, October 26th. Finally, Leerink Swann set a $80.00 price target on shares of CVS Health and gave the company an “outperform” rating in a research report on Thursday, August 9th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, eleven have issued a buy rating and two have given a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $90.04.

COPYRIGHT VIOLATION NOTICE: This article was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another domain, it was stolen and reposted in violation of international copyright and trademark laws. The original version of this article can be accessed at https://www.thecerbatgem.com/2018/11/14/cvs-health-corp-cvs-holdings-trimmed-by-finemark-national-bank-trust.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Further Reading: What are the economic characteristics of a bear market?

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.